Laser Focus World is an industry bedrock—first published in 1965 and still going strong. We publish original articles about cutting-edge advances in lasers, optics, photonics, sensors, and quantum technologies, as well as test and measurement, and the shift currently underway to usher in the photonic integrated circuits, optical interconnects, and copackaged electronics and photonics to deliver the speed and efficiency essential for data centers of the future.

Our 80,000 qualified print subscribers—and 130,000 12-month engaged online audience—trust us to dive in and provide original journalism you won’t find elsewhere covering key emerging areas such as laser-driven inertial confinement fusion, lasers in space, integrated photonics, chipscale lasers, LiDAR, metasurfaces, high-energy laser weaponry, photonic crystals, and quantum computing/sensors/communications. We cover the innovations driving these markets.

Laser Focus World is part of Endeavor Business Media, a division of EndeavorB2B.

Laser Focus World Membership

Never miss any articles, videos, podcasts, or webinars by signing up for membership access to Laser Focus World online. You can manage your preferences all in one place—and provide our editorial team with your valued feedback.

Magazine Subscription

Can you subscribe to receive our print issue for free? Yes, you sure can!

Newsletter Subscription

Laser Focus World newsletter subscription is free to qualified professionals:

The Daily Beam

Showcases the newest content from Laser Focus World, including photonics- and optics-based applications, components, research, and trends. (Daily)

Product Watch

The latest in products within the photonics industry. (9x per year)

Bio & Life Sciences Product Watch

The latest in products within the biophotonics industry. (4x per year)

Laser Processing Product Watch

The latest in products within the laser processing industry. (3x per year)

Get Published!

If you’d like to write an article for us, reach out with a short pitch to Sally Cole Johnson: [email protected]. We love to hear from you.

Photonics Hot List

Laser Focus World produces a video newscast that gives a peek into what’s happening in the world of photonics.

Following the Photons: A Photonics Podcast

Following the Photons: A Photonics Podcast dives deep into the fascinating world of photonics. Our weekly episodes feature interviews and discussions with industry and research experts, providing valuable perspectives on the issues, technologies, and trends shaping the photonics community.

Editorial Advisory Board

  • Professor Andrea M. Armani, University of Southern California
  • Ruti Ben-Shlomi, Ph.D., LightSolver
  • James Butler, Ph.D., Hamamatsu
  • Natalie Fardian-Melamed, Ph.D., Columbia University
  • Justin Sigley, Ph.D., AmeriCOM
  • Professor Birgit Stiller, Max Planck Institute for the Science of Light, and Leibniz University of Hannover
  • Professor Stephen Sweeney, University of Glasgow
  • Mohan Wang, Ph.D., University of Oxford
  • Professor Xuchen Wang, Harbin Engineering University
  • Professor Stefan Witte, Delft University of Technology

Prescribing The Future: How MangoRx Is Shaking Up Telemedicine With A Fresh Platform

--News Direct--

By Anthony Termini, Benzinga

Since Covid-19, telemedicine has been expanding significantly, with 44% of physicians using it at least weekly and 40% daily in the U.S. in 2023. The industry is seen by some as a new frontier for patient education and access to medicine and care.

The DEA Opens The Digital Door To The Telemedicine Industry

Before the pandemic, the primary way a patient would get a drug prescription was through an in-person visit with a doctor. The Drug Enforcement Agency (DEA) loosened those restrictions, allowing physicians to prescribe “controlled medications” over the phone and via video conference.

That’s been good for companies in the direct-to-consumer telehealth industry. One of the players in this business is MangoRx or Mangoceuticals, Inc. (NASDAQ: MGRX), which develops a variety of men's health and wellness products and services.

Working with Surescripts, which helps coordinate all the parties in the prescription process, MangoRx recently transitioned its telemedicine platform to a newly developed DEA-approved telemedicine operating system. The new system allows MangoRx’s third-party doctor network to prescribe and offer controlled substances. These include Prime Protocol by MangoRx, powered by Kyzatrex, an Oral Testosterone Replacement Therapy and other hormone replacement treatments.

According to Jacob Cohen, CEO and co-founder of MangoRx, the company is dedicated to “revolutionizing patient care,” and the new system enhances patient management by “offering seamless doctor visits, prescription auto-refills, and overall health management.”

MangoRx is joined in the telehealth space by companies like Hims & Hers Health (NYSE: HIMS), a San Francisco-based telehealth company; Maximus Tribe, a compound pharmaceuticals company that also offers coaching and is based in Santa Monica, California; and Nu Image Medical, a Tampa, Florida-based company that sells weight loss, hormone replacement, sexual health, and general wellness products.

Cohen argues, however, that MangoRx is setting a new benchmark for excellence in telemedicine. The company believes that the steps it is taking create meaningful competitive advantages over other companies in the space.

MangoRx’s Digital Leap Shortens Time To Market

MangoRx, which currently offers therapy options for erectile dysfunction, hair growth and hormone replacement, intends to use the new operating system to roll out new weight loss treatment options. These include an oral dissolvable GLP-1 tablet that includes Semaglutide and Tirzepatide, the ingredients in some of the most popular prescription weight loss medicines.

The company’s new operating system helps it accelerate the ability to introduce other new product lines, the first of which is the dissolvable tablet they have branded as Slim and Trim. This brand will help MangoRx capitalize on the significant demand for GLP-1 weight loss treatments for both men and women.

MangoRx expects these products will be available to patients before the end of the third quarter and that this new addition will help it to substantially grow revenue moving forward. The company says its new operating system will enable it to respond quickly to market needs and marks an important milestone for MangoRx, representing a significant advancement in its capabilities.

Amanda Hammer, COO of MangoRx, says that the company has a “commitment to regulatory compliance and innovation” and that the new operating system’s cutting-edge technology puts it in a position to continue “revolutionizing patient care in the telemedicine industry.”

MangoRx notes that the system is fully HIPAA-compliant to ensure that all operations adhere to stringent regulatory standards. The new system includes robust security measures to protect patient data and maintain the highest levels of confidentiality.

The system upgrade accompanies a redesigned website with an improved user interface to optimize the customer experience and enhance workflows. The combination creates real-time data tracking and seamless integration that enhance operational efficiency and improve patient engagement.

Featured photo by LinkedIn Sales Solutions on Unsplash.

Benzinga is a leading financial media and data provider, known for delivering accurate, timely, and actionable financial information to empower investors and traders.

This post contains sponsored content. This content is for informational purposes only and is not intended to be investing advice.

Contact Details

Benzinga

+1 877-440-9464

info@benzinga.com

Company Website

http://www.benzinga.com

View source version on newsdirect.com: https://newsdirect.com/news/prescribing-the-future-how-mangorx-is-shaking-up-telemedicine-with-a-fresh-platform-772119124

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.